Sonoma Pharmaceuticals, Inc.
Ticker: 1367083
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 6.41+47.4% | 4.35-22.3% | 5.60+39.3% | 4.02+12.9% | 3.56-0.6% | 3.58+5.6% | 3.39+8.0% | 3.14 |
| Total Income | 6.41+47.4% | 4.35-22.3% | 5.60+39.3% | 4.02+12.9% | 3.56-0.6% | 3.58+5.6% | 3.39+8.0% | 3.14 |
| EXPENSES | ||||||||
| Expenditure | 6.45+28.2% | 5.03-15.3% | 5.94+16.2% | 5.11+11.1% | 4.60+3.8% | 4.43-2.9% | 4.56+14.6% | 3.98 |
| Tax | 0.00+100.0% | -0.13+35.0% | -0.20 | 0.00-100.0% | 0.01-93.3% | 0.15+0.0% | 0.15+350.0% | -0.06 |
| PROFIT | ||||||||
| PBT | -0.33+65.3% | -0.95-30.1% | -0.73+41.1% | -1.24-34.8% | -0.92-100.0% | -0.46+54.0% | -1.00-8.7% | -0.92 |
| Net Profit | -0.33+59.8% | -0.82-54.7% | -0.53+57.3% | -1.24-33.3% | -0.93-52.5% | -0.61+46.5% | -1.14-31.0% | -0.87 |
| KEY METRICS | ||||||||
| OPM % | -0.62%+14.97pp | -15.59%-9.58pp | -6.01%+21.26pp | -27.27%+1.66pp | -28.93%-5.18pp | -23.75%+10.84pp | -34.59%-7.70pp | -26.90% |
| NPM % | -5.15%+13.68pp | -18.83%-9.30pp | -9.53%+21.38pp | -30.91%-4.87pp | -26.04%-8.99pp | -17.04%+16.66pp | -33.71%-6.11pp | -27.60% |
| EPS | -0.09+81.3% | -0.48-50.0% | -0.32+57.9% | -0.76-20.6% | -0.63-6.8% | -0.59-742.9% | -0.07+12.5% | -0.08 |
Corporate Events
Board MeetingSNOA
202616Sep
Board Meeting
Annual Meeting of Stockholders to elect Mr. Jerry McLaughlin…
SEC Filing ↗ Board MeetingSNOA
202619Aug
Board Meeting
Adjourned special meeting of stockholders did not achieve qu…
SEC Filing ↗ Board MeetingSNOA
202624Jun
Board Meeting
Special Stockholders' Meeting to vote on the reincorporation…
SEC Filing ↗